NFIX mutations affecting the DNA-binding domain cause a peculiar overgrowth syndrome (Malan syndrome): a new patients series.

Fiorella Gurrieri, Maria Luigia Cavaliere, Anita Wischmeijer, Corrado Mammì, Giovanni Neri, Maria Antonietta Pisanti, Giulia Rodella, Carmelo Laganà, Manuela Priolo

Risultato della ricerca: Contributo in rivistaArticolo in rivista

14 Citazioni (Scopus)

Abstract

The Nuclear Factor I-X (NFIX) is a member of the nuclear factor I (NFI) protein family and is deleted or mutated in a subset of patients with a peculiar overgrowth condition resembling Sotos Syndrome as well as in patients with Marshall-Smith syndrome. We identified three additional patients with this phenotype each carrying a different new mutation affecting the DNA-binding/dimerization domain of the NFIX protein. The present report further adds weight to the hypothesis that mutations in DNA-binding/dimerization domain are likely to cause haploinsufficiency of the NFIX protein and confirms that NFIX is the second gene that should be tested in individuals with overgrowth conditions resembling Sotos syndrome, previously tested negative for NSD1 mutations. We then propose to consider this overgrowth syndrome (namely Malan syndrome) and Marshall-Smith syndrome NFIX-related diseases
Lingua originaleEnglish
pagine (da-a)488-491
Numero di pagine4
RivistaEuropean Journal of Medical Genetics
Volume58
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • DNA-Binding/dimerization domain
  • Overgrowth syndrome

Fingerprint

Entra nei temi di ricerca di 'NFIX mutations affecting the DNA-binding domain cause a peculiar overgrowth syndrome (Malan syndrome): a new patients series.'. Insieme formano una fingerprint unica.

Cita questo